The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions
- DOI
- 10.2217/fon-2023-0824
- Published
- 2024-02-13
- Container
- Future Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2217/fon-2023-0824,
title = {The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring
<i>NRG1</i>
gene fusions},
author = {Dong-Wan Kim and Alison M Schram and Antoine Hollebecque and Kazumi Nishino and Teresa Macarulla and Sun Young Rha and Michaël Duruisseaux and Stephen V Liu and Mohammed Najeeb Al Hallak and Kumiko Umemoto and Claas Wesseler and James M Cleary and Christoph Springfeld and Cindy Neuzillet and Andrew Joe and Shekeab Jauhari and Jim Ford and Koichi Goto},
year = {2024},
journal = {Future Oncology},
doi = {10.2217/fon-2023-0824},
url = {https://doi.org/10.2217/fon-2023-0824}
}RIS
TY - JOUR
TI - The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring
<i>NRG1</i>
gene fusions
AU - Dong-Wan Kim
AU - Alison M Schram
AU - Antoine Hollebecque
AU - Kazumi Nishino
AU - Teresa Macarulla
AU - Sun Young Rha
AU - Michaël Duruisseaux
AU - Stephen V Liu
AU - Mohammed Najeeb Al Hallak
AU - Kumiko Umemoto
AU - Claas Wesseler
AU - James M Cleary
AU - Christoph Springfeld
AU - Cindy Neuzillet
AU - Andrew Joe
AU - Shekeab Jauhari
AU - Jim Ford
AU - Koichi Goto
PY - 2024
JO - Future Oncology
DO - 10.2217/fon-2023-0824
UR - https://doi.org/10.2217/fon-2023-0824
ER - APA
Kim, D., Schram, A. M., Hollebecque, A., Nishino, K., Macarulla, T., Rha, S. Y., Duruisseaux, M., Liu, S. V., Hallak, M. N. A., Umemoto, K., Wesseler, C., Cleary, J. M., Springfeld, C., Neuzillet, C., Joe, A., Jauhari, S., Ford, J., & Goto, K. (2024). The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions. Future Oncology. https://doi.org/10.2217/fon-2023-0824
Source records
- crossref · retrieved 2026-09-27T16:26:33.003Z